Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

Protagonist Therapeutics shares surge as FDA approves J&J-partnered psoriasis drug

Protagonist Therapeutics (NASDAQ:PTGX) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 and older weighing at least 40 kg.

Leia mais: Protagonist Therapeutics shares surge as FDA approves J&J-partnered psoriasis drug